Moreover, the results showed that BUB1 was suppressed after DUXAP8 knockdown and that the DUXAP8 knockdown-mediated suppression of BUB1 was reversed by miR-490-5 inhibitors in HCC cells (Figures 8G,H). Here, DUXAP8 is linked to hepatocellular carcinoma.